Is Ocean Biomedical Stock a Good Investment?
Ocean Biomedical Investment Advice | OCEAW |
- Examine Ocean Biomedical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Ocean Biomedical's leadership team and their track record. Good management can help Ocean Biomedical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Ocean Biomedical's business and its evolving consumer preferences.
- Compare Ocean Biomedical's performance and market position to its competitors. Analyze how Ocean Biomedical is positioned in terms of product offerings, innovation, and market share.
- Check if Ocean Biomedical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Ocean Biomedical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Ocean Biomedical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Ocean Biomedical is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Ocean Biomedical Stock
Researching Ocean Biomedical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Ocean Biomedical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Ocean Biomedical's research are outlined below:
| Ocean Biomedical is way too risky over 90 days horizon | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical appears to be risky and price may revert if volatility continues | |
| Ocean Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (958.43 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| Ocean Biomedical has a poor financial position based on the latest SEC disclosures |
Ocean Biomedical Quarterly Liabilities And Stockholders Equity |
|
Ocean Biomedical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | (0.03) | (0.03) | |
| Return On Equity | 0.01 | 0.01 |
Determining Ocean Biomedical's profitability involves analyzing its financial statements and using various financial metrics to determine if Ocean Biomedical is a good buy. For example, gross profit margin measures Ocean Biomedical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Ocean Biomedical's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Ocean Biomedical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ocean Biomedical. Check Ocean Biomedical's Beneish M Score to see the likelihood of Ocean Biomedical's management manipulating its earnings.
Basic technical analysis of Ocean Stock
As of the 21st of November, Ocean Biomedical holds the Semi Deviation of 12.8, coefficient of variation of 1188.5, and Risk Adjusted Performance of 0.0731. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ocean Biomedical, as well as the relationship between them. Please check Ocean Biomedical information ratio, as well as the relationship between the potential upside and kurtosis to decide if Ocean Biomedical is priced some-what accurately, providing market reflects its current price of 0.0385 per share. As Ocean Biomedical appears to be a penny stock we also advise to check out its total risk alpha numbers.Understand Ocean Biomedical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Ocean Biomedical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0731 | |||
| Market Risk Adjusted Performance | (5.18) | |||
| Mean Deviation | 13.95 | |||
| Semi Deviation | 12.8 | |||
| Downside Deviation | 14.54 | |||
| Coefficient Of Variation | 1188.5 | |||
| Standard Deviation | 26.86 | |||
| Variance | 721.29 | |||
| Information Ratio | 0.0806 | |||
| Jensen Alpha | 2.29 | |||
| Total Risk Alpha | (0.80) | |||
| Sortino Ratio | 0.1489 | |||
| Treynor Ratio | (5.19) | |||
| Maximum Drawdown | 211.06 | |||
| Value At Risk | (23.47) | |||
| Potential Upside | 29.32 | |||
| Downside Variance | 211.32 | |||
| Semi Variance | 163.72 | |||
| Expected Short fall | (21.36) | |||
| Skewness | 4.48 | |||
| Kurtosis | 28.62 |
| Risk Adjusted Performance | 0.0731 | |||
| Market Risk Adjusted Performance | (5.18) | |||
| Mean Deviation | 13.95 | |||
| Semi Deviation | 12.8 | |||
| Downside Deviation | 14.54 | |||
| Coefficient Of Variation | 1188.5 | |||
| Standard Deviation | 26.86 | |||
| Variance | 721.29 | |||
| Information Ratio | 0.0806 | |||
| Jensen Alpha | 2.29 | |||
| Total Risk Alpha | (0.80) | |||
| Sortino Ratio | 0.1489 | |||
| Treynor Ratio | (5.19) | |||
| Maximum Drawdown | 211.06 | |||
| Value At Risk | (23.47) | |||
| Potential Upside | 29.32 | |||
| Downside Variance | 211.32 | |||
| Semi Variance | 163.72 | |||
| Expected Short fall | (21.36) | |||
| Skewness | 4.48 | |||
| Kurtosis | 28.62 |
Consider Ocean Biomedical's intraday indicators
Ocean Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ocean Biomedical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.14 | |||
| Daily Balance Of Power | (1.03) | |||
| Rate Of Daily Change | 0.86 | |||
| Day Median Price | 0.0416 | |||
| Day Typical Price | 0.0406 | |||
| Market Facilitation Index | 0.0062 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 54.85 |
Ocean Stock media impact
Far too much social signal, news, headlines, and media speculation about Ocean Biomedical that are available to investors today. That information is available publicly through Ocean media outlets and privately through word of mouth or via Ocean internal channels. However, regardless of the origin, that massive amount of Ocean data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ocean Biomedical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ocean Biomedical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ocean Biomedical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ocean Biomedical alpha.
Ocean Biomedical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Ocean Biomedical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.